ADMA BIOLOGICS INC (ADMA) Stock Analyst Ratings
USA - NASDAQ:ADMA - US0008991046 - Common Stock
15.56 USD
-0.14 (-0.89%)
15.5001 USD
-0.06 (-0.38%)
ChartMill assigns a Buy % Consensus number of 84% to ADMA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 27.8. This target is 78.63% above the current price.
ADMA was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about ADMA.
In the previous month the buy percentage consensus was at a similar level.
ADMA was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-08 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2025-03-04 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-11-08 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2024-11-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-10-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-20 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-09 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-07-09 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-06-20 | Mizuho | Maintains | Buy -> Buy |
| 2024-05-10 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-05-10 | Mizuho | Maintains | Buy -> Buy |
| 2024-05-10 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2024-05-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-01 | Mizuho | Maintains | Buy -> Buy |
| 2024-02-29 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-02-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-01-22 | Mizuho | Maintains | Buy -> Buy |
| 2024-01-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-12-19 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-11-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-10 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-08-10 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2023-08-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-03-27 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-08 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-03 | HC Wainwright & Co. | Maintains | Buy |
| 2022-11-10 | Mizuho | Maintains | Buy |
| 2022-10-13 | Mizuho | Initiate | Buy |
ADMA BIOLOGICS INC / ADMA FAQ
Can you provide the average price target for ADMA BIOLOGICS INC stock?
10 analysts have analysed ADMA and the average price target is 27.8 USD. This implies a price increase of 78.63% is expected in the next year compared to the current price of 15.56.
How do analysts rate ADMA BIOLOGICS INC (ADMA)?
The consensus rating for ADMA BIOLOGICS INC (ADMA) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.